This relation between ADMA, obesity, and IR is further supported by interventional studies, which have shown that weight loss was associated with a lowering of circulating ADMA levels in obese individuals, which in turn was accompanied by an increase in insulin sensitivity and NO production [46, 47]. This evidence concerns the gene INS and obesity disorder.